Category: Latest News
-
Accenture Shares Rise After Q1 Results and Bookings Beat Forecasts
Accenture (NYSE:ACN) shares climbed 3.8% in premarket trading on Thursday after the consulting and professional services group delivered first-quarter results that exceeded market expectations, supported by solid revenue growth and a sharp increase in new client bookings. For the quarter ended November 30, 2025, Accenture reported adjusted earnings of $3.94 per share, beating analyst forecasts…
-
Etsy Shares Climb After Company Unveils $750 Million Buyback Program
Etsy Inc (NYSE:ETSY) shares rose 2.2% in premarket trading on Thursday after the online marketplace operator announced a new authorization to repurchase up to $750 million of its own stock. The company said that, when combined with more than $200 million still available under its existing buyback program, the new authorization brings Etsy’s total potential…
-
Trump Media Shares Jump on $6 Billion Merger Deal With TAE Technologies
Trump Media & Technology Group (NASDAQ:DJT) shares surged in premarket trading on Thursday, climbing about 27% to roughly $13.30 after the company announced plans to merge with privately held fusion energy developer TAE Technologies. The transaction, structured as an all-stock merger, places a valuation of more than $6 billion on the combined group. Under the…
-
Athira Pharma Shares Surge After Securing Rights to Phase 3 Breast Cancer Therapy
Athira Pharma Inc (NASDAQ:ATHA) shares soared 73.4% in premarket trading on Thursday after the clinical-stage biopharmaceutical company announced it has obtained worldwide rights to develop and commercialize lasofoxifene, a late-stage breast cancer drug currently being evaluated in Phase 3 trials. Athira has entered into an exclusive global licensing agreement with Sermonix Pharmaceuticals for the selective…
-
Soligenix Shares Jump on Encouraging Data for Behçet’s Disease Therapy
Soligenix Inc (NASDAQ:SNGX) shares rose 5.2% on Thursday after the company released positive findings from a Phase 2a clinical study evaluating SGX945 for the treatment of oral ulcers associated with Behçet’s Disease. The biopharmaceutical company reported that seven of the eight patients enrolled in the study experienced meaningful clinical benefits during the four-week treatment phase.…
-
ON Semiconductor Shares Rise After GaN Partnership With GlobalFoundries
ON Semiconductor Corporation (NASDAQ:ON) shares advanced about 3% on Thursday after the company unveiled a strategic collaboration with GlobalFoundries (NYSE:GFS) to jointly develop and produce next-generation gallium nitride (GaN) power semiconductor devices. The agreement will initially center on 650-volt GaN solutions, combining GlobalFoundries’ 200mm enhancement-mode GaN-on-silicon manufacturing process with ON Semiconductor’s expertise in silicon-based drivers,…
-
Abivax Shares Gain After 22 Scientific Abstracts Accepted for ECCO 2026
Abivax SA ADR (NASDAQ:ABVX) shares rose 2.6% in premarket trading on Thursday after the clinical-stage biotechnology company announced that 22 scientific abstracts have been accepted for presentation at the European Crohn’s and Colitis Organization’s (ECCO) 21st Annual Congress, scheduled for February 2026. The accepted presentations will highlight new and existing data on obefazimod, Abivax’s investigational…
-
Ryvyl Shares Sink After Investors Back Reverse Stock Split Plan
Ryvyl Inc (NASDAQ:RVYL) shares plunged nearly 30% in premarket trading on Thursday after shareholders voted to approve a reverse stock split, a move aimed at helping the company retain its Nasdaq listing. At the company’s annual meeting held on December 15, investors authorized a reverse split in a range between 1-for-20 and 1-for-50. Shareholders also…
-
Cintas Lifts Full-Year Guidance After Beating Q2 Estimates on Margins and Growth
Cintas Corp (NASDAQ:CTAS) posted better-than-expected second-quarter results and raised its outlook for the full fiscal year, supported by solid organic growth, expanding margins and strong cash generation. The update pushed the company’s shares up around 3% in premarket trading. For the quarter ended November 30, the uniform rental and business services group reported diluted earnings…
-
Integer Shares Climb After Activist Investor Reportedly Takes Stake and Pushes Strategic Review
Shares of Integer Holdings Corp (NYSE:ITGR) rose 3.4% in premarket trading on Thursday following reports that activist investor Irenic Capital Management has built a stake of more than 3% in the medical-device outsourcing specialist and is pressing for changes, including a potential sale of the company. According to The Wall Street Journal, Irenic—now among Integer’s…